5 terminated. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 3 | 3 | Terminated 3 |
Follow SARS-CoV2: new trials by email Literature Review of SARS-CoV2 trials Research Report on SARS-CoV2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 Patients BIO101, Placebo - Covid-19, SARS-CoV2 | Phase 2 / Phase 3 | Terminated | Biophytis | 238 | 2020-08-26 | 2026-08-12 |
| Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 Janus Kinase Inhibitor (ruxolitinib), Placebo - Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 | Phase 2 / Phase 3 | Terminated | Vanderson Geraldo Rocha | 5 | 2020-08-14 | 2021-04-08 |
| Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 Hyperbaric oxygen - SARS (Severe Acute Respiratory Syndrome), Cytokine Storm | Phase 2 / Phase 3 | Terminated | Karolinska Institutet | 34 | 2020-06-03 | 2023-01-09 |
| Novel Agents for Treatment of High-risk COVID-19 Positive Patients Ivermectin, Camostat Mesilate, Artemesia annua - COVID, Sars-CoV2 | Phase 2 | Terminated | Susanne Arnold | 13 | 2020-05-01 | 2022-01-20 |
| Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 BMS-986253 - Solid Tumor, Sars-CoV2 | Phase 2 | Terminated | Columbia University | 43 | 2020-04-16 | 2025-05-22 |
COVID-19 (3) · Coronavirus Infections (1) · Cytokine Release Syndrome (1) · Hematologic Neoplasms (1) · Respiratory Distress Syndrome (1) · Severe Acute Respiratory Syndrome (1)
Coronaviridae Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Coronavirus Infections (2) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Inflammation (1) · Neoplasms (1)
Artesunate (1) · HuMax-IL8 (1) · Hyperbaric Oxygenation (1) · Ivermectin (1) · Janus Kinase Inhibitors (1) · camostat (1) · ruxolitinib (1)
Biophytis (1) · Columbia University (1) · Karolinska Institutet (1) · Susanne Arnold (1) · Vanderson Geraldo Rocha (1)
United States (3) · Brazil (2) · Belgium (1) · France (1) · Germany (1) · Puerto Rico (1) · Sweden (1)
Anders Kjellberg, MD (1) · Capucine Morelot-Panzini, MD (1) · Kenny Rodriguez-Wallberg, MD, PhD (1) · Mark N Stein, MD (1) · Peter Lindholm, MD, PhD (1) · Susanne Arnold, MD (1)
PMID 33430924, PMID 34226219, PMID 37510965, PMID 38545090, PMID 39393522